|
- 现金
- 501 元
- 精华
- 0
- 帖子
- 135
- 注册时间
- 2007-10-19
- 最后登录
- 2013-7-17
|
下面是国际学术期刊上有关Nitazoxanide最新的文献。一 可以用来证明其是真实的，并不是某些广告，肆意夸大疗效；二 供有兴趣的战友查查看看
1 Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication
Antiviral Research, Volume 77, Issue 1, January 2008, Pages 56-63
Brent E. Korba, Abigail B. Montero, Kristine Farrar, Karen Gaye, Sampa Mukerjee, Marc S. Ayers, Jean-François Rossignol
2 Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin
Gastroenterology, Volume 136, Issue 3, March 2009, Pages 856-862
Jean–François Rossignol, Asem Elfert, Yehia El–Gohary, Emmet B. Keeffe
3 Nitazoxanide: Beyond Parasites Toward a Novel Agent for Hepatitis C
Gastroenterology, Volume 136, Issue 3, March 2009, Pages 760-763
Jama M. Darling, Michael W. Fried
4 972 INTERIM RESULTS: SINGLE CENTER PILOT EFFICACY STUDY OF NITAZOXANIDE PLUS PEGYLATED ALPHA-2A INTERFERON AND RIBAVIRIN IN PRIOR GENOTYPE 1 NONRESPONDERS WITH HCV INDUCED CIRRHOSIS
Journal of Hepatology, Volume 50, Supplement 1, April 2009, Page S353
B. Yoffe, K. Gasitashvili, V. Khaoustov
5 832 EVALUATION OF A 4 WEEK LEAD-IN PHASE WITH NITAZOXANIDE PRIOR TO NITAZOXANIDE+PEGINTERFERON IN TREATING CHRONIC HEPATITIS C
Journal of Hepatology, Volume 48, Supplement 2, 2008, Page S312
J.F. Rossignol, A. Elfert, E.B. Keeffe
6 Nitazoxanide is an Effective Antiviral Agent Against Both HBV and HCV replication in vitro
Antiviral Research, Volume 74, Issue 3, June 2007, Page A40
Brent Korba, Muller Abigail, Ayers Marc, Jean-François Rossignol
7 A Role for Nitazoxanide in Combination with STAT-C Agents for Inhibition of HCV Replication and the Potential for the Prevention of Viral Resistance
Antiviral Research, Volume 82, Issue 2, May 2009, Page A20
Brent Korba, Jeffery Glenn, Menashe Elazar, Jean-François Rossignol
8 1059 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN NONRESPONDERS (NR) WITH CHRONIC HCV GENOTYPE 1: WEEK 28 INTERIM ANALYSIS
Journal of Hepatology, Volume 50, Supplement 1, April 2009, Pages S385-S386
M. Shiffman, A. Ahmed, I. Jacobson, R. Pruitt, E. Keeffe
9 1049 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE PLUS PEGINTERFERON AND RIBAVIRIN IN HCV GENOTYPE 1 PATIENTS: INTERIM ANALYSIS SHOWS INCREASE IN EVR
Journal of Hepatology, Volume 50, Supplement 1, April 2009, Page S381
B. Bacon, M. Shiffman, J. Lim, A. Berman, V. Rustgi, E. Keeffe
10 68 RANDOMIZED CONTROLLED TRIAL OF NITAZOXANIDE-PEGINTERFERON-RIBAVIRIN, NITAZOXANIDE-PEGINTERFERON AND PEGINTERFERON-RIBAVIRIN IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 4
Journal of Hepatology, Volume 48, Supplement 2, 2008, Page S30
J.F. Rossignol, A. Elfert, Y. El-Gohary, E.B. Keeffe
11 831 RANDOMIZED DOUBLE BLIND PLACEBO-CONTROLLED TRIAL OF NITAZOXANIDE IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 4
Journal of Hepatology, Volume 48, Supplement 2, 2008, Pages S311-S312
J.F. Rossignol, S.M. Kabil, Y. El-Gohary, E.B. Keeffe
12 Nitazoxanide: A potential novel agent for hepatitis C
Darryn Potosky and Charles Howell
Current Hepatitis Reports, Volume 8, Number 2 / 2009年5月 |
|
楼主: 闹心啊
发表于 2009-10-18 16:46
凑个热闹……希望重视一下，这里有医生不了，发个话。
